Home
Conditions
Small Lymphocytic Lymphoma

Clinical trial condition

Small Lymphocytic Lymphoma

Explore clinical trials studying Small Lymphocytic Lymphoma. Study availability and eligibility vary by location and protocol.

162 public trials 44 recruiting studies

Refine in advanced search Browse all conditions

Small Lymphocytic Lymphoma trial results

Completed

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

NCT03263637

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, +42 more
Locations: Research Site Aachen, Germany

Research Site Bonn, Germany

Research Site Göttingen, Germany

Research Site Heidelberg, Germany

View Trial Details

Completed

Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

NCT01497496

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)

NCT02242045

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +24 more
Locations: Aichi, Japan

Miyagi, Japan

Tokyo, Japan

View Trial Details

Completed

A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers

NCT01117142

Conditions: CLL (Chronic Lymphocytic Leukemia), Chronic Disease, Disease Attributes, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia

NCT01109069

Conditions: B Cell Lymphoma, B-Cell Diffuse Lymphoma, B-cell Chronic Lymphocytic Leukemia, +41 more
Locations: Stanford University Stanford, California, United States

Stanford, California, United States

University of Chicago Chicago, Illinois, United States

Boston, Massachusetts, United States

View all 16 locations

View Trial Details

Completed

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01611090

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Berkeley, California, United States

Duarte, California, United States

View all 155 locations

View Trial Details

Completed

Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma

NCT01239875

Conditions: Adult Diffuse Mixed Cell Lymphoma, Adult Diffuse Small Cleaved Cell Lymphoma, Adult Grade III Lymphomatoid Granulomatosis, +37 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT01578707

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +27 more
Locations: Site #408 La Jolla, California, United States

Site #377 Los Angeles, California, United States

Site #403 Santa Maria, California, United States

Site #038 Stanford, California, United States

View all 76 locations

View Trial Details

Completed

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

NCT00974233

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: St Vincent Regional Cancer Center Green Bay, Wisconsin, United States

Bellin Memorial Hospital Green Bay, Wisconsin, United States

Mercy Health System Heme/Onc Janesville, Wisconsin, United States

Gundersen Clinic La Crosse, Wisconsin, United States

View Trial Details

Completed

Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

NCT01699152

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: GRU Augusta, Georgia, United States

DFCI Boston, Massachusetts, United States

OSU Columbus, Ohio, United States

SCRI Nashville, Tennessee, United States

View Trial Details

Small Lymphocytic Lymphoma

Small Lymphocytic Lymphoma trial results

Related conditions